Antiphospholipid antibodies: a new risk factor for restenosis after percutaneous transluminal coronary angioplasty?
about
Impact of Antiphospholipid Syndrome and/or Systemic Lupus Erythematosus on the Long-term Adverse Cardiovascular Outcomes in Patients After Percutaneous Coronary Intervention: A Systematic Review and Meta-analysisAntiphospholipid syndrome; its implication in cardiovascular diseases: a review.Recurrent stent thrombosis in a patient with antiphospholipid syndrome and dual anti-platelet therapy non-responsiveness.Long-term outcome of patients with antiphospholipid syndrome who undergo percutaneous coronary intervention.Antiphospholipid antibodies correlate with stroke severity and outcome in patients with antiphospholipid syndrome.
P2860
Antiphospholipid antibodies: a new risk factor for restenosis after percutaneous transluminal coronary angioplasty?
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
Antiphospholipid antibodies: a ...... sluminal coronary angioplasty?
@en
Antiphospholipid antibodies: a ...... sluminal coronary angioplasty?
@nl
type
label
Antiphospholipid antibodies: a ...... sluminal coronary angioplasty?
@en
Antiphospholipid antibodies: a ...... sluminal coronary angioplasty?
@nl
prefLabel
Antiphospholipid antibodies: a ...... sluminal coronary angioplasty?
@en
Antiphospholipid antibodies: a ...... sluminal coronary angioplasty?
@nl
P2093
P2860
P1433
P1476
Antiphospholipid antibodies: a ...... sluminal coronary angioplasty?
@en
P2093
Agatina AL
Cristina G
Domenico P
P2860
P304
P356
10.3109/08916939809003861
P577
1998-01-01T00:00:00Z